Login to Your Account



Verus Announces Presence With $98M Series A Round

By Brady Huggett


Friday, June 10, 2005
Verus Pharmaceuticals Inc., a company with no technology platform, no products and no plans for R&D, raised total funding of $98 million in its Series A round. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription